Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04522544
Title Durvalumab (MEDI4736) and Tremelimumab in Combination With Either Y-90 SIRT or TACE for Intermediate Stage HCC With Pick-the-winner Design
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Universitätsklinikum Bonn RECRUITING Bonn 53127 Germany Details
Universitätsklinikum Essen RECRUITING Essen 45147 Germany Details
Universitätsklinikum Freiburg RECRUITING Freiburg 79106 Germany Details
Medizinische Hochschule Hannover RECRUITING Hannover 30625 Germany Details
Universitätsklinikum Jena RECRUITING Jena 07747 Germany Details
Universitätsklinikum Köln RECRUITING Köln 50937 Germany Details
Universtitätsklinikum Schleswig-Holstein RECRUITING Lübeck 23538 Germany Details
Klinikum rechts der Isar der Technischen Universität München RECRUITING München 81675 Germany Details
München Klinik Bogenhausen RECRUITING München 81925 Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field